Home > PJ (current issue) > The Society / News Centre | Search

The Pharmaceutical Journal
Vol 278 No 7433 p29
6 January 2007


Society summary


New guidance on safe practice in the disposal of Controlled Drugs

A new publication from the Royal Pharmaceutical Society sets out key points to enable pharmacists to dispose of Controlled Drugs safely, effectively and within the law.

Entitled “Guidance for pharmacists on the safe destruction of Controlled Drugs: England, Scotland and Wales”, the new document has been produced to ensure that the destruction of CDs within pharmacies is undertaken safely and in accordance with the requirements of the Misuse of Drugs Regulations 2001, as amended.

The new guidance is also designed to help pharmacists comply with the relevant Waste Regulations in order to minimise the pollution and health risks that may be caused by incorrect disposal or destruction of CDs.

Some elements of the new guidance are not statutory requirements but are included because the Society considers them to be good practice that pharmacists should follow wherever practicable.

The following are among the main points covered in the guidance:

CDs returned from care homes In England and Wales, pharmacists are not able to accept waste medicines, including CDs, from care homes that provide nursing care. In Scotland, the Scottish Parliament has recently approved legislation that allows pharmacies to accept a range of waste, including CDs, from all care homes.

CDs returned by patients Patient-returned CDs must not be reused. To avoid storage problems and an increased security risk, they should be destroyed as soon as possible. The Society advises pharmacists to keep a record of their return (not in the CD register) and destruction. Pharmacists are currently permitted to destroy patient-returned CDs without the need for an authorised witness. However, the Society advises them to ensure that the destruction is witnessed by another member of staff, preferably another pharmacist or a pharmacy technician.

Unwanted pharmacy stock Pharmacy stock of obsolete, expired or unwanted Schedule 2 CDs not returned by patients can only be destroyed in the presence of an authorised person. The guidance includes the full list of authorised witnesses for each country.

Disposal of waste medicines All medicines should be disposed of in a safe and appropriate manner. Medicines should be disposed of in relevant waste containers that are sent for incineration. They should not be disposed of in the sewerage system.

Waste management licences Having considered the risks posed by destruction of CDs in pharmacies, the Environment Agency, which covers England and Wales, has taken the view that pharmacies should not be expected to obtain a waste management licence for denaturing CDs, which it sees as a low risk activity. The Scottish Environment Protection Agency is currently considering the issue in relation to proportionality and risk and is expected to reach a decision later in the year.

Guidance on specific formulations The guidance includes specific information about the destruction of solid dose formulations, liquid dose formulations, parenteral formulations, Fentanyl patches and aerosol formulations.

The guidance has been developed by the Society in collaboration with other pharmacy bodies, including the Company Chemists Association, Community Pharmacy Wales, the National Pharmacy Association, the Pharmaceutical Services Negotiating Committee and the Scottish Pharmaceutical General Council.

The content of the document will be reviewed later in the year following the receipt of clarification on some issues and the appointment of accountable officers by health trusts and boards (PJ, 9 December 2006, p707).

The six-page document can be downloaded via the Controlled Drugs page within the “Use of medicines” section of the Society’s website. Pharmacists without access to the internet can obtain a copy of the guidance from Heidi Wright, Royal Pharmaceutical Society, 1 Lambeth High Street, London SE1 7JN (tel 020 7572 2602). Queries about the guidance should also be addressed to Ms Wright.

Back to Top


©The Pharmaceutical Journal